Long-acting formulation of a new muscarinic receptor antagonist for the treatment of overactive bladder

Author： Teng Lesheng Jiang Chaojun Sun Fengying Li Chunmei Teng Lirong Meng Qingfan Lee Robert J. Li Youxin

ISSN： 1464-5246

Source： Journal of Microencapsulation, Vol.30, Iss.2, 2013-03, pp. : 116-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darifenacin: a selective M₃ muscarinic receptor antagonist for the treatment of overactive bladder

By Smith Phillip P Lai H Henry Appell Rodney A

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 723-732

Future Medicine

Access to resources Recommend Favorite

Long‐acting muscarinic antagonist + long‐acting beta agonist versus long‐acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta‐analysis

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 8, 2015-11 ,pp. : 1153-1159

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy and tolerability of tarafenacin, a new muscarinic acetylcholine receptor M3 antagonist in patients with overactive bladder; randomised, double‐blind, placebo‐controlled phase 2 study

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 2, 2015-02 ,pp. : 242-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Pharmacology of Paliperidone Palmitate A Parenteral Long-Acting Formulation for the Treatment of Schizophrenia

Reviews on Recent Clinical Trials, Vol. 7, Iss. 1, 2012-02 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite

Quantitative Analysis of the Levels of Expression of Muscarinic Receptor Subtype RNA in the Detrusor Muscle of Patients with Overactive Bladder

By Hinata N.

Molecular Diagnosis, Vol. 8, Iss. 1, 2004-01 ,pp. : 17-22

Adis International

Access to resources Recommend Favorite